Cargando…
The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
Transketolase (TKT), which is a metabolic enzyme in the nonoxidative phase of the pentose phosphate pathway (PPP), plays an important role in providing cancer cells with raw materials for macromolecular biosynthesis. The ectopic expression of TKT in hepatocellular carcinoma (HCC) was reported previo...
Autores principales: | Li, Minle, Zhang, Xuping, Lu, Ying, Meng, Sen, Quan, Haoyu, Hou, Pingfu, Tong, Pan, Chai, Dafei, Gao, Xiaoge, Zheng, Junnian, Tong, Xuemei, Bai, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965636/ https://www.ncbi.nlm.nih.gov/pubmed/31949131 http://dx.doi.org/10.1038/s41419-020-2225-6 |
Ejemplares similares
-
Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation
por: Li, Minle, et al.
Publicado: (2022) -
Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021) -
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011) -
Helicobacter hepaticus Infection Promotes Hepatitis and Preneoplastic Foci in Farnesoid X Receptor (FXR) Deficient Mice
por: Swennes, Alton G., et al.
Publicado: (2014) -
Post-translational modifications of EZH2 in cancer
por: Li, Zhongwei, et al.
Publicado: (2020)